BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28696522)

  • 21. Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.
    Pomerri F; Crimì F; Veronese N; Perin A; Lacognata C; Bergamo F; Boso C; Maretto I
    Dis Colon Rectum; 2017 Nov; 60(11):1184-1191. PubMed ID: 28991083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study.
    Davids JS; Alavi K; Andres Cervera-Servin J; Choi CS; Sturrock PR; Sweeney WB; Maykel JA
    Int J Surg; 2014 Dec; 12(12):1295-9. PubMed ID: 25448648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Reynolds IS; McNamara DA; Kay EW; O'Neill B; Deasy J; Burke JP
    J Surg Oncol; 2018 Dec; 118(7):1129-1134. PubMed ID: 30261095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
    Jalil O; Afaq A; Ganeshan B; Patel UB; Boone D; Endozo R; Groves A; Sizer B; Arulampalam T
    Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
    Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
    Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
    Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic Implications of Magnetic Resonance Imaging-detected Extramural Venous Invasion of Rectal Cancer.
    Lee HG; Kim CW; Jang JK; Park SH; Kim YI; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2023 Mar; 22(1):129-135. PubMed ID: 36460579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.
    Leccisotti L; Gambacorta MA; de Waure C; Stefanelli A; Barbaro B; Vecchio FM; Coco C; Persiani R; Crucitti A; Tortorelli AP; Giordano A; Valentini V
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):657-66. PubMed ID: 25687534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
    Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer.
    Chandramohan A; Mittal R; Dsouza R; Yezzaji H; Eapen A; Simon B; John R; Singh A; Ram TS; Jesudason MR; Masih D; Karuppusami R
    Colorectal Dis; 2022 Apr; 24(4):428-438. PubMed ID: 34954863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
    Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
    Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Aker M; Ganeshan B; Afaq A; Wan S; Groves AM; Arulampalam T
    Dis Colon Rectum; 2019 Feb; 62(2):163-170. PubMed ID: 30451764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary?
    Ayez N; Alberda WJ; Burger JW; Eggermont AM; Nuyttens JJ; Dwarkasing RS; Willemssen FE; Verhoef C
    Ann Surg Oncol; 2013 Jan; 20(1):155-60. PubMed ID: 22875644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.